Patents Assigned to Toxinvent Ou
  • Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment
    Patent number: 10668166
    Abstract: The present invention relates to novel anthracycline derivatives comprising two oxazolidine cycles and the preparation of said anthracycline derivatives. Furthermore, antibody-drug conjugates (ADCs) comprising the novel anthracycline derivatives and the use of such ADCs in the prevention and treatment of cancer are disclosed.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: June 2, 2020
    Assignee: Toxinvent Ou
    Inventors: Ain Uustare, Ivan Ogibalov, Olga T{hacek over (s)}ubrik, Andrus Tasa, Uno Mäeorg, Ago Rinken